A detailed history of D. E. Shaw & Co., Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,756,099 shares of BSX stock, worth $178 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,756,099
Holding current value
$178 Million
% of portfolio
0.14%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.96 - $84.0 $68.4 Million - $78.7 Million
937,465 Added 114.52%
1,756,099 $147 Million
Q2 2024

Aug 14, 2024

SELL
$67.33 - $77.71 $39.1 Million - $45.1 Million
-580,159 Reduced 41.48%
818,634 $63 Million
Q1 2024

May 15, 2024

BUY
$57.6 - $68.62 $50.7 Million - $60.3 Million
879,341 Added 169.28%
1,398,793 $95.8 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $30.1 Million - $35.7 Million
-618,105 Reduced 54.34%
519,452 $30 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $1.42 Million - $1.55 Million
-28,268 Reduced 2.42%
1,137,557 $60.1 Million
Q2 2023

Aug 14, 2023

BUY
$49.72 - $54.64 $34.5 Million - $37.9 Million
694,070 Added 147.13%
1,165,825 $63.1 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $16 Million - $17.8 Million
-355,371 Reduced 42.96%
471,755 $23.6 Million
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $39.4 Million - $47 Million
-994,886 Reduced 54.6%
827,126 $38.3 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $31.4 Million - $93.7 Million
-854,832 Reduced 31.93%
1,822,012 $70.6 Million
Q2 2022

Aug 15, 2022

BUY
$35.24 - $47.1 $73.7 Million - $98.6 Million
2,092,621 Added 358.19%
2,676,844 $99.8 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $35.7 Million - $39.3 Million
-872,392 Reduced 59.89%
584,223 $25.9 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $43.3 Million - $51.1 Million
1,138,662 Added 358.12%
1,456,615 $61.9 Million
Q3 2021

Nov 15, 2021

BUY
$41.23 - $45.88 $8.95 Million - $9.96 Million
217,113 Added 215.3%
317,953 $13.8 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $63.3 Million - $72.6 Million
-1,640,904 Reduced 94.21%
100,840 $4.31 Million
Q1 2021

May 17, 2021

SELL
$35.27 - $39.67 $289 Million - $326 Million
-8,205,986 Reduced 82.49%
1,741,744 $67.3 Million
Q4 2020

Feb 16, 2021

BUY
$33.15 - $41.97 $310 Million - $392 Million
9,342,156 Added 1542.69%
9,947,730 $358 Million
Q3 2020

Nov 16, 2020

SELL
$34.44 - $42.23 $87.6 Million - $107 Million
-2,543,728 Reduced 80.77%
605,574 $23.1 Million
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $5.95 Million - $7.7 Million
-196,944 Reduced 5.89%
3,149,302 $111 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $80.1 Million - $142 Million
3,101,659 Added 1268.12%
3,346,246 $109 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $4.83 Million - $5.79 Million
127,665 Added 109.19%
244,587 $11.1 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $12.3 Million - $13.3 Million
-305,601 Reduced 72.33%
116,922 $4.76 Million
Q2 2019

Aug 14, 2019

SELL
$34.91 - $42.98 $7.93 Million - $9.76 Million
-227,153 Reduced 34.96%
422,523 $18.2 Million
Q1 2019

May 15, 2019

BUY
$32.91 - $40.75 $17.2 Million - $21.4 Million
524,028 Added 417.06%
649,676 $24.9 Million
Q4 2018

Feb 14, 2019

BUY
$31.73 - $39.04 $1.37 Million - $1.69 Million
43,218 Added 52.43%
125,648 $4.44 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $27 Million - $31.8 Million
-822,564 Reduced 90.89%
82,430 $3.17 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $93.7 Million - $120 Million
-3,492,231 Reduced 79.42%
904,994 $29.6 Million
Q1 2018

May 15, 2018

SELL
$25.2 - $28.54 $27 Million - $30.6 Million
-1,071,968 Reduced 19.6%
4,397,225 $120 Million
Q4 2017

Feb 14, 2018

BUY
$24.79 - $29.8 $120 Million - $144 Million
4,828,654 Added 753.84%
5,469,193 $136 Million
Q3 2017

Nov 14, 2017

BUY
$26.26 - $29.17 $16.8 Million - $18.7 Million
640,539
640,539 $18.7 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $146B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.